Single-sex Controlled Human Schistosomiasis Infection: Safety & Dose

See also
Status	Clinical Trial	Phase
Completed	`NCT04115072` - Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study	Phase 2/Phase 3
Not yet recruiting	`NCT05999825` - Sm-p80 Schistosomiasis Challenge Study	Phase 2
Completed	`NCT00463931` - Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana	N/A
Completed	`NCT00276224` - Iron Supplementation in Schistosomiasis and Soil Transmitted Helminths Control Programmes in Zambia	N/A
Completed	`NCT00215267` - The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda	N/A
Completed	`NCT03845140` - L-PZQ ODT in Schistosoma Infected Children	Phase 3
Completed	`NCT01512277` - Clinical Trial of Bilhvax,a Vaccine Candidate Against Schistosomiasis	Phase 1
Active, not recruiting	`NCT03910972` - Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults	Phase 1/Phase 2
Completed	`NCT05085470` - Repeated Controlled Human Schistosoma Mansoni Infection	N/A
Recruiting	`NCT05868005` - Delivering a Multi-disease Screening Tool to Migrant Populations	N/A
Active, not recruiting	`NCT01869465` - Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis	N/A
Completed	`NCT01553552` - Schistosomiasis Effect on Response to Vaccines, Anaemia and Nutritional Status of Children of Northern Senegal	N/A
Recruiting	`NCT04589390` - Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension	Phase 2
Completed	`NCT02868385` - Repeated Doses of Praziquantel in Schistosomiasis Treatment (RePST)	Phase 3
Recruiting	`NCT05762393` - A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Sm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and Madagascar	Phase 1
Not yet recruiting	`NCT06182176` - Effectiveness and Cost-effectiveness of Integrated Model for Malaria and Helminth Control	N/A
Active, not recruiting	`NCT05292391` - Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults	Phase 1
Completed	`NCT03110757` - A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults	Phase 1
Completed	`NCT01154049` - Study to Evaluate the Safety of the Vaccine Prepared sm14 Against Schistosomiasis	Phase 1
Active, not recruiting	`NCT05354258` - Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children	N/A

NCT number	NCT02755324
Study type	Interventional
Source	Leiden University Medical Center
Contact
Status	Completed
Phase	N/A
Start date	October 27, 2016
Completion date	January 21, 2019

Single-sex Controlled Human Schistosomiasis Infection: Safety and Dose Finding

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms